XTL Biopharmaceuticals Ltd. (XTLB)

USD 1.13

(-3.02%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - -459 Thousand 1.46 Million 28 Thousand 69 Thousand 52 Thousand
Cost of Revenue - 1000.00 1000.00 1000.00 - -
Gross Profit - -460 Thousand 1.46 Million 27 Thousand 69 Thousand 52 Thousand
Operating Expenses 765 Thousand 880 Thousand 1.03 Million 948 Thousand 842 Thousand 793 Thousand
Selling, General and Administrative Expenses 734 Thousand 850 Thousand 1 Million 910 Thousand 807 Thousand 755 Thousand
Research and Development Expenses 31 Thousand 30 Thousand 30 Thousand 38 Thousand 35 Thousand 38 Thousand
Other Expenses - - - - - -
Cost and Expenses 765 Thousand 880 Thousand 1.03 Million 948 Thousand 842 Thousand 793 Thousand
Operating Income -765 Thousand -880 Thousand -1.03 Million -948 Thousand -842 Thousand -793 Thousand
Interest Expense - 468 Thousand 21 Thousand 16.99 Thousand 29 Thousand 80 Thousand
Income Tax Expense - 961 Thousand -1.46 Million -166 Thousand -69 Thousand -7.63 Million
Earnings before Tax -1.78 Million -1.34 Million 435 Thousand -782 Thousand -1.34 Million 2.98 Million
Net Income -1.78 Million -2.3 Million 1.9 Million -616 Thousand -1.27 Million 2.98 Million
Earnings Per Share Basic -0.00 -0.42 0.36 -0.12 -0.25 0.58
Earnings Per Share Diluted -0.00 -0.42 0.31 -0.12 -0.25 0.58
Weighted Average Shares Outstanding 544.95 Million 5.44 Million 5.31 Million 5.14 Million 5.14 Million 5.14 Million
Weighted Average Shares Outstanding (Diluted) 544.9 Million 5.44 Million 6.15 Million 5.14 Million 5.14 Million 5.14 Million
Gross Margin - 1.00 1.00 0.96 1.00 1.00
EBIT Margin - 0.84 -1.70 -38.75 -3.88 -86.38
Profit Margin - 5.03 1.30 -22.00 -18.52 57.42
EBITDA -764 Thousand -879 Thousand -1.03 Million -947 Thousand - -792 Thousand
Earnings Before Tax Margin - 1.92 -0.70 -33.86 -12.20 -15.25

Income Statement Charts